INFILTRATING IMMUNE CELL PROPORTIONS PREDICT ANTI-TNF RESPONSE IN COLON BIOPSIES

Provided are methods of predicting responsiveness of a subject having an inflammatory bowel disease (IBD) to a tumor necrosis factor (TNF)-alpha inhibitor, by analyzing a frequency of at least one subpopulation of immune cells in a tissue biopsy of the subject. Also provided are methods of selecting...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STAROVETSKY, Elina, VALLANIA, Francesco, MAIMON, Naama, SHEN-ORR, Shai S, GAUJOUX, Renaud, KHATRI, Purvesh
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator STAROVETSKY, Elina
VALLANIA, Francesco
MAIMON, Naama
SHEN-ORR, Shai S
GAUJOUX, Renaud
KHATRI, Purvesh
description Provided are methods of predicting responsiveness of a subject having an inflammatory bowel disease (IBD) to a tumor necrosis factor (TNF)-alpha inhibitor, by analyzing a frequency of at least one subpopulation of immune cells in a tissue biopsy of the subject. Also provided are methods of selecting a treatment for a subject and kits for determining responsiveness of the subject to treatment with a TNF-alpha inhibitor. L'invention concerne des procédés de prédiction de la sensibilité d'un sujet ayant une maladie intestinale inflammatoire (IBD) à un inhibiteur du facteur de nécrose tumorale (TNF)-alpha, par analyse d'une fréquence d'au moins une sous-population de cellules immunitaires dans une biopsie de tissu du sujet. L'invention concerne également des procédés de sélection d'un traitement pour un sujet et des kits de détermination de la sensibilité du sujet à un traitement avec un inhibiteur du TNF-alpha.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2017175228A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2017175228A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2017175228A13</originalsourceid><addsrcrecordid>eNqNirEKwjAQQLs4iPoPB84FG5F2rfGiB-ldSE4cS5E4iRbq_2MHP8DpPXhvWQRiR15jq8RnoK67MoJF7yFECRKVhNPseCKr0LJSqewgYgpzQCAGK14YjiQhEaZ1sXgMzylvflwVW4dqL2Ue332exuGeX_nT38TsqrqqD8Y0bbX_7_oCZycwXQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INFILTRATING IMMUNE CELL PROPORTIONS PREDICT ANTI-TNF RESPONSE IN COLON BIOPSIES</title><source>esp@cenet</source><creator>STAROVETSKY, Elina ; VALLANIA, Francesco ; MAIMON, Naama ; SHEN-ORR, Shai S ; GAUJOUX, Renaud ; KHATRI, Purvesh</creator><creatorcontrib>STAROVETSKY, Elina ; VALLANIA, Francesco ; MAIMON, Naama ; SHEN-ORR, Shai S ; GAUJOUX, Renaud ; KHATRI, Purvesh</creatorcontrib><description>Provided are methods of predicting responsiveness of a subject having an inflammatory bowel disease (IBD) to a tumor necrosis factor (TNF)-alpha inhibitor, by analyzing a frequency of at least one subpopulation of immune cells in a tissue biopsy of the subject. Also provided are methods of selecting a treatment for a subject and kits for determining responsiveness of the subject to treatment with a TNF-alpha inhibitor. L'invention concerne des procédés de prédiction de la sensibilité d'un sujet ayant une maladie intestinale inflammatoire (IBD) à un inhibiteur du facteur de nécrose tumorale (TNF)-alpha, par analyse d'une fréquence d'au moins une sous-population de cellules immunitaires dans une biopsie de tissu du sujet. L'invention concerne également des procédés de sélection d'un traitement pour un sujet et des kits de détermination de la sensibilité du sujet à un traitement avec un inhibiteur du TNF-alpha.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PHYSICS ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171012&amp;DB=EPODOC&amp;CC=WO&amp;NR=2017175228A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171012&amp;DB=EPODOC&amp;CC=WO&amp;NR=2017175228A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STAROVETSKY, Elina</creatorcontrib><creatorcontrib>VALLANIA, Francesco</creatorcontrib><creatorcontrib>MAIMON, Naama</creatorcontrib><creatorcontrib>SHEN-ORR, Shai S</creatorcontrib><creatorcontrib>GAUJOUX, Renaud</creatorcontrib><creatorcontrib>KHATRI, Purvesh</creatorcontrib><title>INFILTRATING IMMUNE CELL PROPORTIONS PREDICT ANTI-TNF RESPONSE IN COLON BIOPSIES</title><description>Provided are methods of predicting responsiveness of a subject having an inflammatory bowel disease (IBD) to a tumor necrosis factor (TNF)-alpha inhibitor, by analyzing a frequency of at least one subpopulation of immune cells in a tissue biopsy of the subject. Also provided are methods of selecting a treatment for a subject and kits for determining responsiveness of the subject to treatment with a TNF-alpha inhibitor. L'invention concerne des procédés de prédiction de la sensibilité d'un sujet ayant une maladie intestinale inflammatoire (IBD) à un inhibiteur du facteur de nécrose tumorale (TNF)-alpha, par analyse d'une fréquence d'au moins une sous-population de cellules immunitaires dans une biopsie de tissu du sujet. L'invention concerne également des procédés de sélection d'un traitement pour un sujet et des kits de détermination de la sensibilité du sujet à un traitement avec un inhibiteur du TNF-alpha.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PHYSICS</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirEKwjAQQLs4iPoPB84FG5F2rfGiB-ldSE4cS5E4iRbq_2MHP8DpPXhvWQRiR15jq8RnoK67MoJF7yFECRKVhNPseCKr0LJSqewgYgpzQCAGK14YjiQhEaZ1sXgMzylvflwVW4dqL2Ue332exuGeX_nT38TsqrqqD8Y0bbX_7_oCZycwXQ</recordid><startdate>20171012</startdate><enddate>20171012</enddate><creator>STAROVETSKY, Elina</creator><creator>VALLANIA, Francesco</creator><creator>MAIMON, Naama</creator><creator>SHEN-ORR, Shai S</creator><creator>GAUJOUX, Renaud</creator><creator>KHATRI, Purvesh</creator><scope>EVB</scope></search><sort><creationdate>20171012</creationdate><title>INFILTRATING IMMUNE CELL PROPORTIONS PREDICT ANTI-TNF RESPONSE IN COLON BIOPSIES</title><author>STAROVETSKY, Elina ; VALLANIA, Francesco ; MAIMON, Naama ; SHEN-ORR, Shai S ; GAUJOUX, Renaud ; KHATRI, Purvesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2017175228A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PHYSICS</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>STAROVETSKY, Elina</creatorcontrib><creatorcontrib>VALLANIA, Francesco</creatorcontrib><creatorcontrib>MAIMON, Naama</creatorcontrib><creatorcontrib>SHEN-ORR, Shai S</creatorcontrib><creatorcontrib>GAUJOUX, Renaud</creatorcontrib><creatorcontrib>KHATRI, Purvesh</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STAROVETSKY, Elina</au><au>VALLANIA, Francesco</au><au>MAIMON, Naama</au><au>SHEN-ORR, Shai S</au><au>GAUJOUX, Renaud</au><au>KHATRI, Purvesh</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INFILTRATING IMMUNE CELL PROPORTIONS PREDICT ANTI-TNF RESPONSE IN COLON BIOPSIES</title><date>2017-10-12</date><risdate>2017</risdate><abstract>Provided are methods of predicting responsiveness of a subject having an inflammatory bowel disease (IBD) to a tumor necrosis factor (TNF)-alpha inhibitor, by analyzing a frequency of at least one subpopulation of immune cells in a tissue biopsy of the subject. Also provided are methods of selecting a treatment for a subject and kits for determining responsiveness of the subject to treatment with a TNF-alpha inhibitor. L'invention concerne des procédés de prédiction de la sensibilité d'un sujet ayant une maladie intestinale inflammatoire (IBD) à un inhibiteur du facteur de nécrose tumorale (TNF)-alpha, par analyse d'une fréquence d'au moins une sous-population de cellules immunitaires dans une biopsie de tissu du sujet. L'invention concerne également des procédés de sélection d'un traitement pour un sujet et des kits de détermination de la sensibilité du sujet à un traitement avec un inhibiteur du TNF-alpha.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2017175228A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
title INFILTRATING IMMUNE CELL PROPORTIONS PREDICT ANTI-TNF RESPONSE IN COLON BIOPSIES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T15%3A48%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STAROVETSKY,%20Elina&rft.date=2017-10-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2017175228A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true